Related Experiment Video
Updated: Mar 3, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7
Wentao Tang1, Meiling Ji1, Guodong He1
1Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
Abstract:
An increasing number of studies have demonstrated that circular RNAs (circRNAs) can regulate gene expression through interacting with microRNAs. In this study, we analyzed the expression of antisense to CDR1as in colorectal cancer (CRC). CDR1as had a higher expression in CRC tissues compared to adjacent, normal mucosa and was positively associated with tumor size, T stage, lymph node metastasis, and poor overall survival (OS). Downregulation of CDR1as suppressed CRC cell proliferation and invasion and increased microRNA-7 (miR-7) expression. Intriguingly, ectopic expression of miR-7 in CRC cells consistently inhibited proliferation and invasion, and the miR-7 inhibitor was able to rescue the function of CDR1as knockdown. Mechanistic studies demonstrated that CDR1as silencing suppressed EGFR and IGF-1R expression, which could be partially blocked by the miR-7 inhibitor. Finally, positive correlations between CDR1as expression and EGFR and IGF-1R expression were observed in CRC samples. Thus, given the importance of CDR1as in blocking miR-7 and positively regulating EGFR and IGF-1R, dysregulated CDR1as expression may play an important role in CRC progression.
Insights
Circular RNAs (circRNAs) like CDR1as are implicated in colorectal cancer (CRC) progression. This study shows CDR1as promotes CRC by inhibiting microRNA-7 (miR-7), thereby upregulating EGFR and IGF-1R, leading to poor survival.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Circular RNAs (circRNAs) are increasingly recognized for their role in regulating gene expression via microRNA (miRNA) interactions.
- Dysregulation of circRNAs is implicated in various cancers, including colorectal cancer (CRC).
Purpose of the Study:
- To investigate the expression and function of antisense to CDR1as (CDR1as) in colorectal cancer (CRC).
- To elucidate the molecular mechanisms underlying CDR1as's role in CRC progression, focusing on its interaction with microRNA-7 (miR-7) and its downstream targets.
Main Methods:
- Analysis of CDR1as expression in CRC tissues versus normal adjacent mucosa.
- Assessment of the correlation between CDR1as expression and clinicopathological features (tumor size, T stage, lymph node metastasis, overall survival).
- In vitro studies involving CDR1as knockdown and miR-7 overexpression/inhibition in CRC cells to evaluate effects on proliferation and invasion.
- Mechanistic investigations into the regulation of Epidermal Growth Factor Receptor (EGFR) and Insulin-like Growth Factor 1 Receptor (IGF-1R) by CDR1as and miR-7.
Main Results:
- CDR1as expression was significantly higher in CRC tissues and correlated with advanced tumor size, T stage, lymph node metastasis, and poorer overall survival.
- Downregulation of CDR1as inhibited CRC cell proliferation and invasion while increasing miR-7 expression.
- Ectopic expression of miR-7 suppressed CRC cell proliferation and invasion, and miR-7 inhibition rescued the effects of CDR1as knockdown.
- CDR1as silencing reduced EGFR and IGF-1R expression, an effect partially reversed by miR-7 inhibition.
- Positive correlations were observed between CDR1as, EGFR, and IGF-1R expression in CRC samples.
Conclusions:
- Dysregulated CDR1as expression plays a significant role in CRC progression.
- CDR1as promotes CRC by sponging miR-7, leading to the upregulation of oncogenes EGFR and IGF-1R.
- CDR1as represents a potential therapeutic target for colorectal cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Experimental RNAi
Inhibition of Cdk Activity
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

